首页> 外文会议>International Symposium on Amyloidosis >EVALUATION OF PLASMA CELL VOLUME AND CLONALITY IN AL (PRIMARY) AMYLOIDOSIS BY ANALYSIS OF PRE AND POST STEM CELL TRANSPLANTATION BONE MARROW CORE BIOPSIES (BMCB)
【24h】

EVALUATION OF PLASMA CELL VOLUME AND CLONALITY IN AL (PRIMARY) AMYLOIDOSIS BY ANALYSIS OF PRE AND POST STEM CELL TRANSPLANTATION BONE MARROW CORE BIOPSIES (BMCB)

机译:通过前后干细胞移植骨髓核心活组织检查分析(BMCB)评价Al(初级)淀粉样蛋白病的血浆细胞体积和克隆性

获取原文

摘要

AL amyloidosis, a monoclonal plasma cell dyscrasia, is the most common form of systemic amyloidosis in the US. The fibrillar amyloid protein, derived from circulating monoclonal immunogiobulin light chains, deposits in tissue and leads to progressive organ failure and death. Amyloidosis can now be successfully treated with high-dose melphalan chemotherapy followed by autologous peripheral blood stem cell transplantation The aim of this study was to examine the effect of stem cell transplantation (SCT) treatment on bone marrow plasma cell (PC) volume and immunogiobulin light chain (LC) clonality in 99 patients (pts) with AL amyloidosis (67X, 21K, 11 no detectable clonality). In 35 pts (25?i, 6K, 4 no detectable clonality), correlation between plasma cell data and free light chain (FLC) levels and ratios was assessed.
机译:Al淀粉样蛋白化,一种单克隆血浆细胞达克西亚,是美国最常见的全身淀粉样蛋白病。衍生自循环单克隆免疫导管轻链,组织沉积物并导致进一步的器官衰竭和死亡的纤维淀粉样蛋白。淀粉样变性现在可以用高剂量蛋白质化疗成功处理,然后成功地治疗,然后通过自体外周血干细胞移植进行本研究的目的是检查干细胞移植(SCT)处理对骨髓血浆细胞(PC)体积和免疫植物蛋白光的影响连锁(LC)99例患者(PTS)的克隆,Al淀粉样症(67倍,21K,11,无可检测的克隆性)。在35分(25℃,6K,4,无可检测的克隆态)中,评估血浆细胞数据和游离轻链(FLC)水平和比率之间的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号